Clinical trial
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
NCT00006371 · H. Lee Moffitt Cancer Center and Research Institute, Other · Terminated
Key facts
| NCT number | NCT00006371 |
|---|---|
| Title | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer |
| Official title | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH Janssen Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | aminoglutethimide, ketoconazole, therapeutic hydrocortisone |
| Enrollment | 2 |
| Start date | May 1, 2000 |
| Primary completion | Dec 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Apr 2, 2004 |
| Last update posted | Sep 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: